IMRT-treated Prostate Cancer Patients Don’t Have Increased Risk of Secondary Disease, Study Reveals
News
Prostate cancer patients treated with intensity-modulated radiation therapy (IMRT) do not have an increased risk of secondary cancers such as leukemia or myelodysplasia, compared to the standard 3D conformal radiotherapy. The ... Read more